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Secondary analysis of an RCT on Emergency Department-
Initiated Tobacco Control: Repeatedly assessed point-prevalence 
abstinence up to 12 months and extension of results through a 
10-year follow-up
Edith Weiss-Gerlach1, William J. McCarthy2, Jürgen Wellmann3, Marie Graunke1, Claudia Spies1, Bruno Neuner1
ABSTRACT
INTRODUCTION Emergency departments (EDs) are opportune places for tobacco 
control interventions. The ‘Tobacco Control in an Urban Emergency Department’ 
(TED) study, ISRCTN41527831, originally evaluated the effect of motivational 
interviewing on-site plus up to four booster telephone calls on 12-month 
abstinence. This study’s aim was to evaluate the effect of the intervention on 
7-day point-prevalence abstinence at 10 years follow-up (primary outcome) as 
well as on repeated point-prevalence abstinence at 1, 3, 6, 12 months and at 10 
years (continual smoking abstinence, secondary outcome).
METHODS At the 10 years follow-up and after informed consent, study participants 
responded to a mailed questionnaire. The primary outcome was analyzed in 
observed-only and in all-cases analyses. The secondary outcomes were analyzed 
using a multiple adjusted GLMM for binary outcomes.
RESULTS Out of 1012 TED-study participants, 986 (97.4%) were alive and 231 
(23.4% of 986) responded to the follow-up at 10 years. For observed-only and 
all-cases analyses, the effect of the baseline intervention on 7-day point-prevalence 
abstinence at the 10 years follow-up was statistically non-significant. However, 
when taking into account all repeated measures, the intervention significantly 
influenced continual abstinence with odds ratio 1.32 (95% CI: 1.01–1.73; 
p=0.042). Baseline motivation, perceived self-efficacy to stop smoking, and 
nicotine dependency were independently associated with long-term continual 
smoking abstinence (all p<0.05).
CONCLUSIONS A conventional analysis failed to confirm a significant effect of the ED-
initiated tobacco control intervention on the point-prevalence abstinence at 10 
years. Results from a more integrative analysis nonetheless indicated an enduring 
intervention effect on continual abstinence among smokers first encountered in 
the emergency department setting 10 years earlier.
ABBREVIATIONS GLMM: generalized linear mixed model, TED: Tobacco Control in an Urban Emergency Department, ED: emergency 
department, RCT: randomized controlled trial, Laocoon: Long-Term-Follow-up of Tobacco Control in an Urban Emergency Department 
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INTRODUCTION
Emergency departments (EDs) are opportune settings 
for promoting healthier lifestyle behaviors and 
preventing disease, including cigarette smoking1,2. 
A 2006 recommendation of the American College of 
Emergency Physicians advocated routine screening of 
ED patients’ smoking status and to advise ED smokers 
to quit3. The recommendation introduced the term 
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‘Emergency Department-Initiated Tobacco Control’ 
for such procedures, typically a combination of on-
site motivational interviewing/counseling, followed 
by either booster interventions or referral to other 
institutions providing smoking cessation counseling3. 
Since 2000, several randomized controlled trials 
(RCTs) evaluated the efficacy of such screening 
and brief intervention efforts, mostly a combination 
of an initial motivational counselling session and 
either booster intervention sessions or referral to 
outpatient services, including tobacco quitlines. 
A recent systematic review and meta-analysis 
identified 11 RCTs and a significant effect of ED-
initiated tobacco control on 7-day point-prevalence 
tobacco abstinence at 1 and 3 months follow-up4. 
Additionally, a statistically significant benefit from 
exposure to the ED-initiated tobacco control services 
was observed, using repeated 7-day point-prevalence 
tobacco abstinence measures (continual tobacco-
use abstinence) up to 12 months post-intervention. 
Pooling the results of all available studies and across 
all follow-up time points, patients in the intervention 
group showed a relative risk (RR) of 1.40 (95% CI: 
1.06–1.86; p=0.02), of being tobacco abstinent4. 
Thus, their chance of being at least momentarily 
abstinent increased by 40%. Continual tobacco-use 
abstinence may be regarded as an important precursor 
to continuous abstinence, the ultimate goal of tobacco 
cessation efforts for several reasons: 1) even transient 
periods of smoking abstinence may yield positive 
health impact, for example, on lung function5; 
2) previous experience with temporary abstinence 
predisposes to further attempts to quit6; and 3) smokers 
typically need several quit attempts before achieving 
long-term abstinence7. The aim of the current study 
was therefore two-fold: First, a 10-year follow-up 
allowed us to evaluate the long-term outcome of 
an ED-initiated tobacco control intervention 10 
years after the initial RCT was stopped8. Secondly, 
by evaluating continual abstinence instead of the 
7-day point-prevalence tobacco abstinence at the 12 
months follow-up, we re-evaluated the initial RCT 
on ED-initiated tobacco control8  and extended the 
analysis of continual abstinence status to  follow-up 
over 10 years. Finally, the multivariable analysis of 
these parameters allowed the identification of baseline 
parameters independently associated with long-term 
continual abstinence.
METHODS
Data sources
The parent study was the randomized, controlled trial 
entitled ‘Tobacco Control in an Urban Emergency 
Department’ (TED), ISRCTN415278318. This 
single-center study was conducted in 2005/2006 
at one campus of the Charité–Universitaetsmedizin 
Berlin, Germany, with the last follow-up taking 
place in January 2008. The emergency department 
at this campus has two subunits, one for surgical 
and one for internal medicine patients. The study 
was conducted in both units. Briefly, 1012 out of 
1044 randomized urban emergency department 
patients had a complete baseline assessment and 
received either motivational interviewing on-site in 
combination with up to four booster phone calls, 
or usual care. Usual care patients received a brief 
leaflet with some general information on smoking 
cessation but no counselling on-site and no booster 
phone calls. Follow-up assessment started one 
month after the motivational interviewing on-site 
and was repeated at 3, 6, and 12 months follow-
up. The predefined outcome was the 7-day point-
prevalence abstinence at the 12 months follow-up, 
showing an adjusted intervention effect versus usual 
care (OR=1.31; 95% CI: 0.91–1.89; p=0.15)8.
Ten-year follow-up 
The ‘Long-Term-Follow-up of Tobacco Control in 
an Urban Emergency Department’ (Laocoon) study 
received ethical committee approval (EA1/238/15) in 
June 2015. Out of 1012 TED-study participants with 
complete baseline questionnaire, 122 (12.1%) were 
not reachable at the follow-up at 12 months. Thus, 
initially 890 study participants received a mailed 
‘study package’, consisting of the study information, 
the consent form and the study questionnaire 
together with a business reply envelope. Successively 
undeliverable mailing addresses, together with the 
122 addresses known to be incorrect were transferred 
to Address Research®, a service provider from the 
German postal service (Deutsche Post AG). This 
service provider has access to official registration 
office data and provides information on national 
addresses, information on tenancy changeover abroad 
(with no further information on target country or a 
specific address) and, in case of death, information 
on the mortality status. Newly retrieved addresses 
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were continuously added into the contact algorithm. 
Study participants of the TED study, who were alive at 
the time of the Laocoon study and who had a known 
current address received the initial study package 
and two postal reminders. A last attempt was made 
to reach potential eligible participants by sending 
a  2-page questionnaire, evaluating the main study 
outcome.
Study measures
All study measures were evaluated by self-
administered postal questionnaire. The predefined 
primary outcome was the 7-day point-prevalence 
abstinence at the 10 years follow-up. This outcome 
was assessed using two questions: ‘Did you smoke 
during the past seven days?’. Those, who answered 
‘daily’ or ‘on xx days’, were asked: ‘During the days 
on which you smoked, how many cigarettes did you 
usually smoke per day?’. Further smoking-status 
related questions concerned the degree of nicotine 
dependency, measured with the Fagerström Test for 
Nicotine Dependency (FTND)9, motivation to stop 
smoking, assessed with a single question ‘When do you 
wish to stop smoking?’ with three possible answers: 
‘Not within the next 6 months’=unmotivated smokers, 
‘Within the next 6 months but not within the next 
4 weeks’=ambivalent smokers and ‘Within the next 
4 weeks’=motivated smokers10,11. Further questions 
evaluated illicit drug use8, alcohol consumption12, 
socioeconomic status8 and the participant’s current 
medical status. The 2-page questionnaire evaluated 
the main study outcome, the heaviness of smoking 
index (HSI13, a short-form of the FTND9), motivation 
to stop smoking10,11 and current medical status.
A secondary study outcome was repeated point-
prevalence abstinence through 10 years of follow-up 
(i.e. 7-day point-prevalence tobacco abstinence at 1, 
3, 6, 12 months and at 10 years, continual abstinence). 
Covariates for adjustments of the multivariable models 
(see Statistical Analysis section) were chosen based 
on their association (p<0.1)14,15 with participant non-
response (Table 1) or because the scientific literature 
had identified them as recognized predictors of 
smoking counseling outcomes, these were: emergency 
department subunit (surgical or internal medicine), 
age, level of nicotine dependency (Fagerström Test), 
partnership status, educational level (university-
entrance diploma), having a family doctor, gender, 
motivation to stop smoking (10-point scale from 1 
to 10 points according to Miller and Rollnick16) and 
Table 1. Predictors of repeated point prevalence abstinence up to 12 months and up to 10 years after
emergency department-initiated tobacco control, results of GLMM analyses (N=1011 )a
Baseline parameter at study entry 
(TED study)
Model 1: Follow-up through 12 
months only
Model 2: Follow-up through 10 years
OR ( 95% CI) p OR ( 95% CI) p
Intervention group vs control group unadjustedb 1.32 (0.99–1.77) 0.062 unadjustedb 1.32 (1.02–1.72) 0.035
Intervention group vs control group adjustedc 1.28 (0.95–1.74) 0.103 adjustedc 1.32 (1.01–1.73) 0.042
Internal medicine subunit vs surgical subunit 1.42 (1.04–1.93) 0.027 1.32 (1.01–1.74) 0.044
Age (years), per additional year 1.01 (0.99–1.02) 0.40 1.01 (0.99–1.02) 0.36
Male vs Female gender 0.97 (0.71–1.32) 0.84 0.93 (0.71–1.23) 0.63
Fagerström test, per additional point 0.88 (0.82–0.95) 0.001 0.89 (0.83–0.94) < 0.001
Motivation to stop smokingd, per additional point 1.20 (1.13–1.28) < 0.001 1.19 (1.13–1.25) < 0.001
Perceived self-efficacy to stop smokinge, per 
additional point
1.18 (1.11–1.26) < 0.001 1.15 (1.09–1.22) < 0.001
Partnership
  Non-smoking partner vs no partnership 1.03 (0.71–1.50) 0.87 1.17 (0.84–1.62) 0.36
  Smoking partner vs no partnership 0.73 (0.51–1.05) 0.087 0.74 (0.54–1.03) 0.071
University-entrance diploma vs none 1.17 (0.86–1.60) 0.32 1.21 (0.92–1.60) 0.17
Family doctor vs none 1.11 (0.79–1.57) 0.55 1.16 (0.85–1.58) 0.34
a1012 participants of the TED study with complete baseline questionnaire data minus one study participant who withdrew his initial participation consent. b With time to 
follow-up as ordinal term and interaction intervention group×time linear (p>0.9). c Plus adjustments. d 10-point scale from 1 to 10 points with higher points indicating higher 
motivation to stop smoking16. e10-point from 1 to 10 points with higher points indicating higher perceived self-efficacy to stop smoking17. TED: Tobacco Control in an Urban 
Emergency Department8 .  GLMM: generalized linear mixed model.  OR: odds ratio. CI: confidence interval.
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perceived self-efficacy to stop smoking (10-point 
scale from 1 to 10 points according to Miller and 
Rollnick17). The lower pole of the two scales referred 
to no motivation/no self-efficacy to stop smoking 
while the upper pole indicated very high motivation/
self-efficacy to stop smoking.
Statistical analysis
The patients’ flow through the follow-up is graphically 
displayed by a lasagna-plot18, a way of showing for all 
study participants the individual course of smoking/
non-smoking and study attrition transitions over all 
follow-up times.
Binary and ordinal variables are depicted as 
absolute and relative numbers. For variables with 
normal distributions, the measures of central 
tendency used are means with standard deviations, 
while for non-normally distributed variables, medians 
and their ranges are used. Differences between two 
independent groups were evaluated in normally 
distributed variables and non-normally distributed 
variables using Student’s t-test and Mann-Whitney-U-
Test, respectively. For binary data such as the primary 
outcome of the Laocoon study (current smoking/non-
smoking status), comparisons between groups were 
done using the chi-squared test.
The secondary study outcome, the effect of the ED-
initiated tobacco control intervention on continual 
abstinence assessed repeatedly until the assessment 
at 12 months (totaling four follow-up times) and 
assessment at 10 years  (thus totaling five follow-
up times), was analyzed by logistic regression for 
repeated, correlated binary outcomes (generalized 
linear mixed models, GLMMs). The GLMM accounts 
for heterogeneity in the effect of the initial tobacco 
control intervention between subjects as well as for 
heterogeneity in the effect over time. A Markov-
type Ante-Dependence covariance structure19,20 was 
employed for the marginal covariance matrix of each 
participant, which entails four and five different 
variance parameters, until 12 months (fourth follow-
up) and until 10 years (fifth follow-up), respectively. 
This approach avoids repeated single tests of repeated 
measurements without taking the correlation with 
the preceding measurement and the preceding test 
statistics into account19. It is reasonable to assume a 
decaying correlation structure between repeated pairs 
of measurements over successive assessment intervals 
and thus a fading-off of the initial tobacco control 
intervention over time. Therefore, three (12-month 
follow-up, Model 1 in Table 1) and four (10-year 
follow-up, Model 2 in Table 1) additional covariances 
were included to capture the variability attributable 
to the transition from one follow-up examination to 
the next and to capture the varying time intervals 
between consecutive follow-up assessments (between 
one month and nine years). These correlations 
may be estimated from the data and are shown in 
Supplementary Table 1. The Ante-Dependence 
covariance structure is also robust in settings with 
dropouts unrelated to the ‘treatment’19, i.e. the tobacco 
cessation counseling in this study (Table 2; eligibility 
at 10 years was not associated with randomization 
status). The randomly assigned treatment group at 
baseline, time of follow-up assessment (one, three, six 
and twelve months as well as 10 years after baseline), 
and their interaction term were entered into the 
model as categorical variables. The interaction term 
was meant to capture an eventual differential effect 
of time in both study arms. The interpretation of the 
main effect of the intervention is that of an overall 
effect of the treatment across all time-points. The 
model was formulated using ‘Proc glimmix’ in SAS 
and the Ante-Dependence covariance structure was 
defined using the random statement:
RANDOM time/subject = id type = ante(1) RESIDUAL.
Although the baseline data were derived from a 
well-balanced RCT with no indication of residual 
confounding (see Table 1 of Nuener et al.8), an 
unadjusted model was considered to be a suboptimal 
solution to modeling effects over such a long time 
span. Adjusting for variables associated with loss 
to follow-up was meant to address potential biases 
caused by differential attrition. 
A p-value of less than 0.05 was defined as 
statistically significant. All statistical analyses were run 
in SPSS (IBM SPSS Statistics for Windows, Version 
25.0. Armonk, NY: IBM Corp) or in SAS University 
Edition®.
RESULTS
Out of 1012 TED-study participants with complete 
baseline questionnaire, 986 (97.3%) were potentially 
eligible for participation in the Laocoon study. Correct 
addresses were identified for 685 study participants 
(69.5%) and of these, 231 (33.7% of the 685) 
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participated in the 10-year follow-up. Seventy-four 
study participants (32.0% of the 231) returned only 
the brief 2-page questionnaire. The details of the 
study participation/non-participation over time are 
shown in Figure 1.
The lasagna-plot (Figure 2) shows the large 
proportion of those already lost to follow-up at 1 
month (the white space above the second bar). 
However, with increasing duration of follow-ups 
and additional follow-up assessments, around 
two-thirds of those lost to follow-up at the assessment 
at 1 month ended up providing follow-up information 
about their smoking status at least one additional 
time. This held true even for those who were lost 
to follow-up between the 1 and 3 months follow-up 
assessments. Thus, over the course of the initial study 
period with a 12-month follow-up, more than 85% of 
study participants provided follow-up information at 
Table 2. Baseline characteristics at the time of inclusion in the TED study in Laocoon-study participants, 
Laocoon-study non-responder and patients with indeterminate postal address (N=986 )
Baseline and follow-up measures 
(TED study)
Current determinate postal address Indeterminate 
postal address
Study participants 
N=231 ( 23.4%)
Non-responder 
N=454 ( 46.0%)
p N=301 ( 30.5%)
Intervention group, n (%) 119 (51.5) 214 (47.1) 0.28 160 (53.2)
Surgical subunit of the ED, n (%) 125 (54.1) 214 (47.1) 0.084 137 (45.5)
Non-smoker at 1 month follow-up (N=654) n (%) 17 (9.5) 21 (7.3) 0.39 19 (10.2)
Non-smoker at 3 months follow-up (N=621) n (%) 25 (14.0) 33 (11.7) 0.48 23 (14.3)
Non-smoker at 6 months follow-up (N=633) n (%) 35 (18.9) 49 (16.9) 0.57 27 (17.1)
Non-smoker at 12 months follow-up (N=671) n (%) 47 (23.6) 49 (15.9) 0.031 33 (20.1)
Age (years) mean ± SD, range 34.9 ± 12.0, (18–68) 31.9 ± 9.9, (18–73) 0.001 30.9 ± 9.3, (18–78)
Female gender, n (%) 103 (44.6) 174 (38.3) 0.14 111 (36.9)
Number of cigarettes smoked per day mean ± SD, range 15.0 ± 9.3, (1–40) 16.9 ± 9.5, (1–60) 0.013 17.0 ± 10.3, (1–60)
Fagerström test mean ± SD 2.9 ± 2.6 3.4 ± 2.5 0.019 3.6 ± 2.6
Motivation to stop smoking 10-point scale, mean ± SD 5.4 ± 2.7 5.7 ± 2.6 0.12 5.7 ± 2.5
Motivation to stop smokinga, n (%)
  unmotivated 135 (58.4) 253 (55.7) 151 (50.2)
  ambivalent 66 (28.6) 143 (31.5) 0.66c 111 (36.9)
  motivated 30 (13.0) 58 (12.8)b 39 (13.0)b
Perceived self-efficacy to stop smoking 10-point scale, 
mean ± SD
5.6 ± 2.9 5.5 ± 2.7 0.12 5.6 ± 2.6
Harmful alcohol consumptiond, n (%) 81 (35.1) 150 (33.0) 0.60 107 (35.5)
Illicit drug usee, n (%) 127 (55.0) 250 (55.1) 0.98 192 (63.8)
Partnership, n (%)
  Non-smoking partner 73 (31.6) 123 (27.1) 0.089 78 (25.9)
  Smoking partner 87 (37.7) 211 (46.5) 130 (43.2)
  No partner 71 (30.7) 120 (26.4) 93 (30.9)
Living in a single household, n (%) 87 (37.7) 165 (36.3) 0.74 123 (40.9)
University-entrance diploma, n (%) 128 (55.4) 206 (45.4) 0.013 156 (51.8)
Net family income/month above medianf in 2006 
(N=187) n (%)
72 (38.5) 138 (41.7) 0.48 80 (34.5)
Family doctor, n (%) 183 (79.2) 330 (72.7) 0.062 189 (62.8)
 a ‘When do you wish to stop smoking?’ (‘Not within the next 6 months’=unmotivated smokers, ‘Within the next 6 months but not within the next 4 weeks’=ambivalent smokers 
and ‘Within the next 4 weeks’=motivated smokers)10,11. b Does not sum up to 100% because of rounding error. c Chi-squared test for trend; d ≥5 points in the AUDIT-PC12. 
e At least one single use within the last 12 months before the TED-study baseline: cannabis, ecstasy, other designer drugs, natural drugs (e.g. Peyote), cocaine, morphine, heroin 
or other opiates8. f 1475€/month8. TED: Tobacco Control in an Urban Emergency Department8. SD: standard deviation. ED: emergency department. AUDIT-PC: Alcohol Use 
Disorders Identification Test–Piccinelli Consumption.
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least once. On the other hand, many study participants 
who participated in the first follow-up assessment at 
one month did not provide further information or 
provided incomplete information in later follow-up 
assessments.
Regarding smoking status over consecutive 
assessments, only 7 out of 986 (0.7%) study 
participants were tobacco abstinent at all follow-
up assessments and presumably stopped smoking 
permanently after the initial smoking cessation 
intervention. These 7 are represented on the lasagna-
plot by the continual blue part of the five follow-up 
charts culminating in the sliver of blue at the bottom 
of the 6th assessment. Only 55 out of 986 (5.6%) 
study participants completed follow-up information 
indicating continual smoking at every assessment. 
These 55 are represented by the largest red ‘slice’ 
one-fifth from the bottom of the 5th follow-up 
assessment. Thus, nearly 94 per cent of study 
participants switched between smoking/non-smoking 
status and study participation/study attrition over the 
course of five assessments conducted over 10 years 
of follow-up.
The total number of non-smokers in both study 
groups and per follow-up interval is given in 
Baseline 1 month 3 months 6 months 12 months 10 years
  1011 673 639 650 685 231
    0 59 86 116 133 112
Figure 1. Flowchart of the study participation process 
(n=1012 )
1,012 study participants in the Tobacco Control in an Urban Emergency Department’ 
(TED)-study
986 potential eligible for participation in the Laocoon-study, 
493 in the intervention group and 493 in the control group
685 eligible for participation in the Laocoon-study, 345 in the intervention group, 
and 366 in the control group
Altogether 231 study participants, of these 74 (32.0%) returned the 2-pages 
questionnaire
505 intervention group
160 (31.7% of 505) 
indeterminate postal 
addresses even through 
inquiry at an official 
postal data provider
226 (65.5% of 345) did 
not respond to overall 
four postal contacts
119 study participants, of whom 
38 (31.9%) returned the 2-pages 
questionnaire
12 deceased after end of 
TED-study
507 control group
141 (27.8% of 507) 
indeterminate postal 
addresses even through 
inquiry at an official 
postal data provider
254 (69.4% of 366) did 
not respond to overall 
four postal contacts
112 study participants, of whom 
36 (32.1%) returned the 2-pages 
questionnaire
13 deceased after end of 
TED-study
1 withdrawn consent /
decision on data deletion
# responder
# quitter
Figure 2. Lasagna-plot and marginal distribution table of smoking status and dropouts over all follow-up 
assessments for the TED and Laocoon studies (N=1011 )
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Supplementary Figure 1. The number of non-smokers 
in the intervention group exceeded the number of 
non-smokers in the control group at all follow-up 
assessments. The highest total numbers of non-
smokers occurred in both study groups at the 12 
months follow-up. At the 10 years follow-up, in 
observed cases-only analysis, the total number of 
non-smokers (the primary outcome of the Laocoon 
study) was 61/119 (51.3%) in the intervention group 
and 51/112 (45.5%) in the control group, p=0.38. 
The corresponding all-cases analysis with penalized 
imputation (non-responder classified as current 
smoker) yielded 61/505 (12.1%) non-smokers in the 
intervention group and 51/506 (10.1%) non-smokers 
in the control group, p=0.31.
Table 1 shows the results after re-analyzing the 
continual abstinence (secondary study outcome of 
the Laocoon study). Through the 12 months follow-
up (adjusted Model 1), the intervention showed 
an independent statistically non-significant effect 
(OR=1.28, 95% CI 0.95–1.74; p = 0.103) but through 
the 10 years follow-up (adjusted model 2), the 
intervention showed a statistically significant effect 
(OR=1.32, 95% CI 1.01–1.73, p=0.042) ( Table 1). 
In this final model, other significant and independent 
associations of continual abstinence up to 10 years 
follow-up with baseline parameter were time to 
follow-up assessment (p<0.001 in all four models), 
smoking-related factors such as higher points on a 
motivation ladder and higher perceived self-efficacy 
to stop smoking, as well as less nicotine dependence 
as measured with the Fagerström test. Patients in 
the internal medicine subunit of the ED had higher 
odds of becoming non-smokers compared to surgical 
patients from the surgical subunit (p=0.027 up to 12 
months follow-up and p=0.044 up to 10 years follow-
up, respectively). The covariance parameter estimates 
for this final model showed nearly identical variance 
for the five measures in each of the four models, 
respectively, and declining correlations between 
consecutive assessments (Supplementary Table 1).
Table 2 compares baseline characteristics of study 
participants in the 10 years follow-up (follow-up 
responder) with those of follow-up non-responders 
who did not respond to any of three contact attempts. 
Table 2 additionally provides information on the 
baseline characteristics of study participants with 
no current addresses identified. Neither exposure 
to the smoking intervention at baseline, nor the 
smoking status up to 6 months after the intervention 
is associated with 10-year loss to follow-up (all 
p>0.05). Higher abstinence rates at 12 months 
follow-up (23.6% vs 15.9%, p=0.031) as well as 
older age at baseline (p<0.001), higher educational 
attainment (p=0.013) and smoking fewer cigarettes 
per day (p=0.013) at baseline and being less tobacco 
dependent (p=0.019) at baseline were significantly 
associated with study participation at the 10 years 
follow-up.
Table 3 shows the baseline characteristics of the 
231 Laocoon-study participants, stratified by smoking 
status at the 10 years follow-up. While there was no 
difference in randomization status (p=0.38), those 
study participants who were tobacco-abstinent at 
the 10 years follow-up were smoking on average 
fewer cigarettes at baseline, were less nicotine 
Table 3. Comparing 10-year non-smokers and current smokers in the Laocoon study on TED-study baseline 
characteristics (N=231 )
Baseline and follow-up measures 
(TED study)
10-year non-smoker 
N=112 ( 48.5%)
10-year smoker
N=119 ( 51.5%)
p
Intervention group, n (%) 61 (54.5) 58 (48.7) 0.38
Surgical subunit of the ED, n (%) 66 (55.5) 59 (52.7) 0.67
Non-smoker at 1 month follow-up (N=179) n (%) 14 (16.3) 3 (3.2) 0.003
Non-smoker at 3 months follow-up (N=179) n (%) 20 (25.0) 5 (5.1) < 0.001
Non-smoker at 6 months follow-up (N=185) n (%) 23 (25.8) 12 (12.5) 0.021
Non-smoker at 12 months follow-up (N=199) n (%) 35 (36.8) 12 (11.5) < 0.001
Age (years) mean ± SD, range 35.5 ± 12.2, (18–65) 34.3 ± 11.8, (18–68) 0.46
Female gender, n (%) 51 (45.5) 52 (43.7) 0.78
Number of cigarettes smoked per day mean ± SD, range 13.4 ± 9.5, (1–40) 16.5 ± 8.9, (1–35) 0.009
Fagerström test mean ± SD 2.5 ± 2.5 3.4 ± 2.6 0.008
Motivation to stop smoking 10-point scale, mean ± SD 5.9 ± 2.8 5.0 ± 2.6 0.058
Continued
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dependent, showed higher motivation to quit smoking 
and reported lower frequency of harmful alcohol 
consumption (all p<0.05). Retrospective postdiction 
of abstinence status up to 12 months, for respondents 
not smoking at the 10 years follow-up rose from 
16.3% at the 1 month follow-up to 36.8% at the 12 
months follow-up while the corresponding abstinence 
for respondents who reported smoking at the 10 
years follow-up rose from 3.2% at 1 month follow-
up to 11.5% at the 12 months follow-up (differences 
between groups: all p<0.05). With regard to baseline 
social influences, tobacco abstainers at the 10 years 
follow-up compared with self-identified smokers 
reported more often having a non-smoking partner 
(42.9% vs 21.0%, p= 0.001) and having attained more 
years of education (p=0.035).
 
DISCUSSION
The long-term follow-up of a randomized controlled 
trial involving emergency department-initiated 
tobacco control allowed analyzing both isolated as well 
as repeated measures of point-prevalence abstinence 
up to 10 years after the initial intervention. While 
there was no effect on the single point-prevalence 
outcome at the 10 years follow-up, evidence obtained 
from the more integrative modeling approach 
suggests a small cumulative impact on repeated 
point-prevalence abstinence across five time-points 
over the entire course of both studies. Moreover, 
several smoking-related baseline parameters were 
significantly associated with continual tobacco 
abstinence over 10 years follow-up. They included 
baseline level of nicotine dependence, motivation to 
quit smoking as well as perceived self-efficacy to quit.
This study is to our knowledge the first attempt to 
evaluate the impact of ED-initiated tobacco control 
on 10-year smoking status and to use continual 
tobacco abstinence as the outcome. Data did not 
exist on loss to follow-up or effect size for a 10-year 
follow-up before the Laocoon study. As far as we 
know, the longest duration of follow-up in previous 
RCTs involving ED-initiated smoking cessation was 
12 months4. Considering the null results at the 12 
months follow-up of the initial study, the single 
observation, longer-term result presented here 
may not be surprising. However, evidence from 
other medical settings suggests mixed effects of 
individually-focused tobacco control interventions on 
long-term tobacco abstinence. In a Chinese smoking 
cessation clinic abstinence rates rose from 27% at the 
1 year follow-up to 38% at the 7 years follow-up21. 
Up to 8 years after termination of a 12-month RCT 
in a dental setting, cessation rates rose by 8 per cent 
and, although not statistically significant, differences 
between study arms persisted (p=0.16)22. Negative 
findings occurred in >2500 high school smokers 
Baseline and follow-up measures 
(TED study)
10-year non-smoker 
N=112 ( 48.5%)
10-year smoker
N=119 ( 51.5%)
p
Motivation to stop smokinga, n (%)
  unmotivated 59 (52.7) 76 (63.9)
  ambivalent 34 (30.4) 32 (26.9) 0.044c
  motivated 19 (17.0)b 11 (9.2)
Perceived self-efficacy to stop smoking 10-point scale, mean ± SD 5.5 ± 2.6 5.4 ± 2.9 0.16
Harmful alcohol consumptiond, n (%) 31 (27.7) 50 (42.0) 0.022
Illicit drug usee, n (%) 57 (50.9) 70 (58.8) 0.23
Partnership, n (%)
  No partner 31 (27.7) 40 (33.6)
0.001  Smoking partner 33 (29.5) 54 (45.4)
  Non-smoking partner 48 (42.9) 25 (21.0)
Living in a single household, n (%) 38 (33.9) 49 (41.2) 0.26
University-entrance diploma, n (%) 70 (62.5) 58 (48.7) 0.035
Net family income/month above medianf in 2006 (N=187) n (%) 31 (33.3) 41 (43.6) 0.15
Family doctor, n (%) 90 (80.4) 93 (78.2) 0.68
a ‘When do you wish to stop smoking?’ (‘Not within the next 6 months’=unmotivated smokers, ‘Within the next 6 months but not within the next 4 weeks’=ambivalent smokers 
and ‘Within the next 4 weeks’=motivated smokers)10,11. b Does not sum up to 100% because of rounding error. c Chi-squared test for trend. d ≥5 points in the AUDIT-PC12. e At 
least one single use within the last 12 months before the TED-study baseline: cannabis, ecstasy, other designer drugs, natural drugs (e.g. Peyote), cocaine, morphine, heroin or 
other opiates8. f 1475€/month8. TED: Tobacco Control in an Urban Emergency Department8. SD: standard deviation. ED: emergency department. AUDIT-PC: Alcohol Use Disorders 
Identification Test–Piccinelli Consumption.
ContinuedTable 3. 
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seven years post-intervention, when motivational 
interviewing plus telephone counseling showed no 
impact on quit rates compared to usual care (14.2% 
vs 13.1%, p=0.61; respectively)23. Likewise, non-
superiority occurred in an RCT with >1600 study 
participants that were prescribed the nicotine patch 
for smoking cessation compared with usual care eight 
years after study participation (non-smoking rates of 
27.6% compared with 26.4%)24.
Individuals who smoke and present to emergency 
departments are typically more than a decade younger 
than patients who smoke and present in the clinical 
setting, with the latter often already suffering from 
tobacco-associated disease. Long waiting lines, the ED 
teachable moment, and the proven efficacy of brief 
smoking cessation intervention in the ED setting 
for up to one year are compelling arguments for 
implementing smoking cessation services into clinical 
routine in EDs3. The median counseling time in the 
ED of the TED study was 13 minutes and the median 
overall initial intervention, together with the four 
booster phone calls, did not exceed 30 minutes8. Thus, 
overall half an hour of individual face-to-face tobacco 
counseling in the ED in combination with booster 
phone calls seems to motivate this harder-to-reach 
smoking group to at least quit smoking temporarily. 
Because of the large number of young patients treated 
in EDs every day, implementation of brief smoking 
cessation interventions in this setting are likely 
to have a significant public health impact3. On an 
individual level and independently of age, gender, 
and educational status, baseline motivation and 
perceived self-efficacy to quit smoking as well as level 
of nicotine dependence were prognostic factors of 
continual tobacco abstinence in the results presented 
here. These smoking-related factors may be routinely 
evaluated using paper-based or electronic devices in 
those ED patients who are eligible for screening and 
brief intervention and who are not directly transferred 
to their medical treatment. Information about both 
baseline parameters helps in tailoring individual 
smoking cessation, e.g. according to the Clinical 
Practice Guidelines for Treating Tobacco Use and 
Dependence25. 
An additional finding of note is the striking 
variability not only in smoking status, for those 
participants who chose to respond to each survey, but 
also in participants’ responsiveness to each survey. 
Switching between smoking, non-smoking and study-
attrition/study-participation appears to be the norm 
and continual abstinence (or continual smoking) the 
exception. Early cessation is no guarantee of long-
term abstinence but early relapse is also no guarantee 
of long-term smoking. It now seems premature to 
assume that no further follow-up outcome data will 
be available from a participant who failed to participate 
in an earlier follow-up assessment. Thus, the idea of 
capturing one single well-defined and validated study 
outcome as a proxy for overall success/failure of a 
tobacco control intervention seems overly pessimistic. 
Episodes of smoking abstinence increased significantly 
over time even among smokers in the control group. 
The significant independent effect of time may reflect 
the cumulative impact of periodic public health tobacco 
control campaigns and repeated exposure to other brief 
clinical interventions. It may also reflect the maturing 
out of smoking behavior from young adulthood into 
middle age, independently of a person’s individual life 
course and his/her interaction with the health care 
system, as well as specific time-period related factors, 
such as the new availability of e-cigarettes.
Limitations
Although attrition status was not differentially 
associated with randomization status, the Laocoon-
study follow-up participants were documentably not 
representative of the original study sample. Overall, 
compared to non-participants, participants in the 
Laocoon study were more often characterized by 
‘protective’ characteristics such as older age (younger 
age was shown to impede the impact of individual 
tobacco counseling in different settings)26-29, lower 
nicotine dependence/fewer cigarettes smoked (a 
strong predictor for cessation success in various 
settings)26,30-32, more years of attained education 
(a known predictor of both success after smoking 
cessation33 as well as higher study adherence in various 
settings including tobacco control studies)26,34-36. In 
univariable comparisons (Table 3), this bias was not 
taken into account and thus, the results have to be 
interpreted with caution. In the multivariable models 
however (Table 1), attrition as a potential source 
of bias was addressed by adjusting for parameters 
associated with non-response in univariate analysis. 
Nevertheless, the results presented here have to be 
regarded as not only deriving from a secondary data 
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analysis, but as being the product of exploratory 
analyses. This is why p-values were not adjusted for 
multiple testing.
The high rate of loss to follow-up between the 12 
months and the 10 years follow-up was to be expected 
for such a long interval, despite several attempts, 
including regulatory inquiries, to increase the number 
of correct addresses and thus the number of potential 
follow-up participants. A response rate of 23% (in 
regard to persons with current postal address) is 
notwithstanding a significant weakness of this study, 
that may not be satisfactory eliminated with elaborate 
analytical approaches.
More confident inferences about modifiable 
influences on the impact of smoking cessation in the 
emergency department setting over time await studies 
that minimize attrition through implementation 
of more rigorous follow-up protocols. There is 
furthermore a need for biological validation of 
smoking status outcomes. While smoking outcomes 
were biologically validated at the 12 months follow-up 
of the parent study8, this was not feasible during this 
postal long-term follow-up.
CONCLUSIONS
Future research in this setting should consider the 
course of ED patients’ compliance/non-compliance 
evaluated in this specific study setting. The unstable 
findings involving smoking/non-smoking status 
highlights the need for analytical approaches that 
take into account this dynamism of outcome. Research 
would probably benefit from repeated assessments 
of 7-day point prevalence smoking status, capturing 
more adequately the picture of the natural course of 
the smoking behavior over time. Furthermore, future 
research should evaluate if the benefit of ED-initiated 
tobacco control increases with more specifically 
tailored interventions and more rigorous treatment 
of tobacco dependence.
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